Protein Analysis in Cerebrospinal Fluid Samples

Awarded Award Notice Posted

Solicitation number
75N95023Q00222
Agency
National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
Awarded
to Amprion, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N95023P00399 Federal contract award
NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Place of performance
San Francisco, California, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Amprion, Inc. was awarded a contract by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to perform protein analysis in cerebrospinal fluid samples. The contract, valued at $1,064,800, was awarded on June 30, 2023 with no set-aside designation specified. This award notice provides details of the contract awarded to Amprion, Inc. to conduct protein analysis in cerebrospinal fluid samples for the National Institute on Drug Abuse.

Notice text

Awarded contract 75N95023P00399 to Amprion, Inc. for 1064800.00 on 2023-06-30.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Protein Analysis in Cerebrospinal Fluid Samples This notice · Award Award Notice
Protein Analysis in Cerebrospinal Fluid Samples Latest solicitation Solicitation
SOURCES SOUGHT: Protein Analysis in Cerebrospinal Fluid Samples (CSF) Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity